Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
作者： Y. P. M. Goekoop-Ruiterman , J. K. De Vries-Bouwstra , C. F. Allaart , D. Van Zeben , P. J. S. M. Kerstens
DOI: 10.1002/ART.21405
关键词: Rheumatology 、 Rheumatoid arthritis 、 Randomized controlled trial 、 Prednisone 、 Arthritis 、 Surgery 、 Internal medicine 、 Infliximab 、 Adverse effect 、 Medicine 、 Combination therapy
摘要: … for treatment in group 4 according to the ITT principle. … 1 and 2 remained at the initial stage of treatment because of a … 3 and 4 had the benefit of a more rapid relief of symptoms and …
vumc.nl
narcis.nl参考文章(38)
Frank C Arnett, None, Revised criteria for the classification of rheumatoid arthritis. Bulletin on The Rheumatic Diseases. ,vol. 38, pp. 1- 6 ,(1989)
Trang L, Borg G, Pettersson H, Lund B, Brodin U, Egsmose C, Berg E, Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. The Journal of Rheumatology. ,vol. 22, pp. 2208- 2213 ,(1995)
van Riel Pl, van 't Hof M, van de Putte Lb, van der Heijde Dm, Development of a disease activity score based on judgment in clinical practice by rheumatologists The Journal of Rheumatology. ,vol. 20, pp. 579- 581 ,(1993)
Agnes van der Heide, The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs Annals of Internal Medicine. ,vol. 124, pp. 699- 707 ,(1996) , 10.7326/0003-4819-124-8-199604150-00001
Robert B. M. Landewé, Maarten Boers, Arco C. Verhoeven, Rene Westhovens, Mart A. F. J. van de Laar, Harry M. Markusse, J. Christiaan van Denderen, Marie Louise Westedt, Andre J. Peeters, Ben A. C. Dijkmans, Piet Jacobs, Annelies Boonen, Désirée M. F. M. van der Heijde, Sjef van der Linden, COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention Arthritis & Rheumatism. ,vol. 46, pp. 347- 356 ,(2002) , 10.1002/ART.10083
E. William St. Clair, D�sir�e M. F. M. van der Heijde, Josef S. Smolen, Ravinder N. Maini, Joan M. Bathon, Paul Emery, Edward Keystone, Michael Schiff, Joachim R. Kalden, Ben Wang, Kimberly DeWoody, Roberta Weiss, Daniel Baker, , Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial Arthritis & Rheumatism. ,vol. 50, pp. 3432- 3443 ,(2004) , 10.1002/ART.20568
A. M. van Gestel, M. L. L. Prevoo, M. A. van't Hof, M. H. van Rijswijk, L. B. A. van de Putte, P. L. C. M. van Riel, Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria Arthritis & Rheumatism. ,vol. 39, pp. 34- 40 ,(1996) , 10.1002/ART.1780390105
Timo Möttönen, Pekka Hannonen, Markku Korpela, Martti Nissilä, Hannu Kautiainen, Jorma Ilonen, Leena Laasonen, Oili Kaipiainen-Seppänen, Per Franzen, Tapani Helve, Juhani Koski, Marianne Gripenberg-Gahmberg, Riitta Myllykangas-Luosujärvi, Marjatta Leirisalo-Repo, Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 46, pp. 894- 898 ,(2002) , 10.1002/ART.10135
J. Martin Bland, DouglasG. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. ,vol. 327, pp. 307- 310 ,(1986) , 10.1016/S0140-6736(86)90837-8
James F. Fries, Catherine A. Williams, Dianne Morfeld, Gurkirpal Singh, John Sibley, Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug–based treatment strategies Arthritis & Rheumatism. ,vol. 39, pp. 616- 622 ,(1996) , 10.1002/ART.1780390412